| NDC Code | 44206-417-06 |
|---|
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (44206-417-06) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (44206-417-91) |
|---|
| Product NDC | 44206-417 |
|---|
| Product Type Name | PLASMA DERIVATIVE |
|---|
| Proprietary Name | Carimune |
|---|
| Proprietary Name Suffix | Nanofiltered |
|---|
| Non-Proprietary Name | Human Immunoglobulin G |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20090210 |
|---|
| End Marketing Date | 20210531 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA102367 |
|---|
| Manufacturer | CSL Behring AG |
|---|
| Substance Name | HUMAN IMMUNOGLOBULIN G |
|---|
| Strength | 6 |
|---|
| Strength Unit | g/1 |
|---|
| Pharmacy Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS] |
|---|